Blue Earth Drug Patent Portfolio

Blue Earth owns 2 orange book drugs protected by 11 US patents Given below is the list of Blue Earth's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11980674 Imaging of metastatic or recurrent cancer 23 Apr, 2042
Active
US12036290 Pharmaceutical formulations 27 Nov, 2041
Active
US11413360 Dual mode radiotracer and—therapeutics 22 Nov, 2038
Active
US10124079 Imaging of metastatic or recurrent cancer 30 Dec, 2035
Active
US10716868 Imaging of metastatic or recurrent cancer 30 Dec, 2035
Active
US10933147 Imaging of metastatic or recurrent cancer 30 Dec, 2035
Active
US10967077 Imaging of metastatic or recurrent cancer 30 Dec, 2035
Active
US10010632 Precursor compound of radioactive halogen-labeled organic compound 28 Nov, 2026
Active
US10953112 Precursor compound of radioactive halogen-labeled organic compound 28 Nov, 2026
Active
US9387266 Precursor compound of radioactive halogen-labeled organic compound 28 Nov, 2026
Active
US5808146 Amino acid analogs for tumor imaging 09 Nov, 2020 Expired


Given below is the list of recent legal activities going on the following drug patents of Blue Earth.

Activity Date Patent Number
Patent litigations
Change in Power of Attorney (May Include Associate POA) 28 Jun, 2024 US10933147
Email Notification 28 Jun, 2024 US10716868
Change in Power of Attorney (May Include Associate POA) 28 Jun, 2024 US10716868
Email Notification 28 Jun, 2024 US10933147
Email Notification 28 Jun, 2024 US10124079
Change in Power of Attorney (May Include Associate POA) 28 Jun, 2024 US10124079
Change in Power of Attorney (May Include Associate POA) 20 Jun, 2024 US10967077
Email Notification 20 Jun, 2024 US10967077
Payment of Maintenance Fee, 4th Year, Large Entity 11 Jan, 2024 US10716868
Payment of Maintenance Fee, 8th Year, Large Entity 03 Jan, 2024 US9387266
Post Issue Communication - Certificate of Correction 10 Jul, 2023 US11413360
Email Notification 23 Dec, 2022 US11413360
Change in Power of Attorney (May Include Associate POA) 23 Dec, 2022 US11413360
Correspondence Address Change 19 Dec, 2022 US11413360
Patent Issue Date Used in PTA Calculation 16 Aug, 2022 US11413360


Blue Earth's Family Patents

Blue Earth drugs have patent protection in a total of 16 countries. It's US patent count contributes only to 36.1% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Blue Earth Drug List

Given below is the complete list of Blue Earth's drugs and the patents protecting them.


1. Axumin

Axumin is protected by 9 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11980674 Imaging of metastatic or recurrent cancer 23 Apr, 2042
(17 years from now)
Active
US10124079 Imaging of metastatic or recurrent cancer 30 Dec, 2035
(11 years from now)
Active
US10716868 Imaging of metastatic or recurrent cancer 30 Dec, 2035
(11 years from now)
Active
US10933147 Imaging of metastatic or recurrent cancer 30 Dec, 2035
(11 years from now)
Active
US10967077 Imaging of metastatic or recurrent cancer 30 Dec, 2035
(11 years from now)
Active
US10010632 Precursor compound of radioactive halogen-labeled organic compound 28 Nov, 2026
(2 years from now)
Active
US10953112 Precursor compound of radioactive halogen-labeled organic compound 28 Nov, 2026
(2 years from now)
Active
US9387266 Precursor compound of radioactive halogen-labeled organic compound 28 Nov, 2026
(2 years from now)
Active
US5808146 Amino acid analogs for tumor imaging 09 Nov, 2020
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Axumin's drug page


2. Posluma

Posluma is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12036290 Pharmaceutical formulations 27 Nov, 2041
(17 years from now)
Active
US11413360 Dual mode radiotracer and—therapeutics 22 Nov, 2038
(14 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Posluma's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List